SCHEMBL25555265

SCHEMBL25555265

CC(C)c1ncc(S)cc1F

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.30
PANK3 Q9H999 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2737358 0.78 AGBL2 (0.32) PANK3
SCHEMBL12041152 0.77 CCR1 (0.35) PANK3
SCHEMBL14225108 0.77 S1PR1 (0.33) PANK3
SCHEMBL12414696 0.75 S1PR1 (0.37)
SCHEMBL12186132 0.75 S1PR3 (0.43)
SCHEMBL31188331 0.75 MEN1 (0.33) PANK3
SCHEMBL21736794 0.75 TET2 (0.33) PANK3
SCHEMBL11922548 0.75 RPS6KA3 (0.33) PANK3
SCHEMBL12190777 0.73 NPC1 (0.37)
SCHEMBL21105492 0.72 PANK3 (0.38) PANK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159532-A1 PARATHYROID HORMONE (PTH) RECEPTOR ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159532-A1 PARATHYROID HORMONE (PTH) RECEPTOR ANTAGONISTS AND USES THEREOF PTH1R, CALCR, VDR TRPV4 328/4885PANK3 1700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.